2002
DOI: 10.1016/s0022-2836(02)00405-9
|View full text |Cite
|
Sign up to set email alerts
|

Production of Functional Single-Chain Fv Antibodies in the Cytoplasm of Escherichia coli

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
117
0

Year Published

2003
2003
2019
2019

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 131 publications
(119 citation statements)
references
References 49 publications
2
117
0
Order By: Relevance
“…The variants were functional upon extraction from the reducing environment of the E. coli cytoplasm, consistent with the absence of a disulfide bridge. Functional cytoplasmic production is also an advantage compared with standard antibodies, which do not fold correctly in the strongly reducing environment of the E. coli cytoplasm, although this can be overcome by using a strain lacking glutathione oxidoreductase and thioredoxin reductase (24), or the antibody scaffold used is isolated or developed for this purpose (4).…”
Section: Discussionmentioning
confidence: 99%
“…The variants were functional upon extraction from the reducing environment of the E. coli cytoplasm, consistent with the absence of a disulfide bridge. Functional cytoplasmic production is also an advantage compared with standard antibodies, which do not fold correctly in the strongly reducing environment of the E. coli cytoplasm, although this can be overcome by using a strain lacking glutathione oxidoreductase and thioredoxin reductase (24), or the antibody scaffold used is isolated or developed for this purpose (4).…”
Section: Discussionmentioning
confidence: 99%
“…Rad) as described (24). The anti-E-tag monoclonal antibodyperoxidase conjugate (Amersham Biosciences) was applied for luminescent detection of the PtsN-E-tag fusion proteins with the procedure described (24).…”
Section: Methodsmentioning
confidence: 99%
“…Furthermore, the secretory expression of most scFv and Fab fragments involves insoluble aggregated forms called inclusion bodies in the periplasm (14,16), and some antibody fragments cannot be expressed even as inclusion bodies (17). Consequently, a few other systems have been developed for the production of functional antibodies from E. coli, for example, direct production of functional scFv in the cytoplasm by the coexpression of disulfide bond chaperones (18), and refolding of recombinant antibody fragments from inclusion bodies in vitro (19).…”
mentioning
confidence: 99%